Nanalysis Scientific Corp.
NSCIF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $22 | $28 | $32 | $35 |
| - Cash | $0 | $0 | $1 | $1 |
| + Debt | $19 | $18 | $16 | $18 |
| Enterprise Value | $40 | $46 | $47 | $52 |
| Revenue | $9 | $10 | $11 | $12 |
| % Growth | -3% | -9.6% | -13.8% | – |
| Gross Profit | $2 | $2 | $3 | $4 |
| % Margin | 21.9% | 24.3% | 25.6% | 34.1% |
| EBITDA | -$0 | -$1 | -$0 | -$6 |
| % Margin | -3.8% | -8.2% | -0% | -49.1% |
| Net Income | -$2 | -$2 | -$1 | -$7 |
| % Margin | -16.2% | -22.2% | -12.3% | -60.6% |
| EPS Diluted | -0.01 | -0.02 | -0.01 | -0.066 |
| % Growth | 50% | -100% | 84.8% | – |
| Operating Cash Flow | -$0 | -$2 | $3 | $1 |
| Capital Expenditures | -$0 | -$0 | -$1 | -$0 |
| Free Cash Flow | -$1 | -$2 | $2 | $1 |